AP NEWS

Europe Multiple Sclerosis Market and Competitive Landscape Report 2018: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares 2014-2023 - ResearchAndMarkets.com

November 8, 2018

DUBLIN--(BUSINESS WIRE)--Nov 8, 2018--The “Europe Multiple Sclerosis Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

Europe Multiple Sclerosis Market and Competitive Landscape - 2018, provides comprehensive insights into Multiple Sclerosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Multiple Sclerosis market size and drug sales. This research also provides insights into Multiple Sclerosis epidemiology and late stage pipeline.

The research is classified into following sections - Multiple Sclerosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Sclerosis pipeline insights covering late stage clinical trials pipeline; Multiple Sclerosis prevalence trends by countries; Multiple Sclerosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:

Multiple Sclerosis pipeline: Find out the drugs in clinical trials for Multiple Sclerosis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Multiple Sclerosis epidemiology: Find out the prevalence of Multiple Sclerosis by countries - Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023 Multiple Sclerosis products: Identify key products marketed and prescribed for Multiple Sclerosis by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK Multiple Sclerosis market size: Find out the market size for Multiple Sclerosis drugs by countries - Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014 Multiple Sclerosis drug sales: Find out the sales of Multiple Sclerosis drugs by countries - Europe, Germany, France, Italy, Spain, UK Multiple Sclerosis drugs sales forecast: Sales forecast for Multiple Sclerosis drugs to 2023 by countries - Europe, Germany, France, Italy, Spain, UK Multiple Sclerosis market share analysis: Find out the market shares of Multiple Sclerosis drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK

For more information about this report visit https://www.researchandmarkets.com/research/jddl7z/europe_multiple?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181108005879/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/08/2018 02:51 PM/DISC: 11/08/2018 02:51 PM

http://www.businesswire.com/news/home/20181108005879/en

AP RADIO
Update hourly